Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nutritional Assessment of Patients With Non-small Cell Lung Cancer Treated With Osimertinib

NCT07559526 is registered in ClinicalTrials.gov with Fundacin Biomedica Galicia Sur as lead sponsor.

NCT NCT07559526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07559526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nutritional Assessment of Patients With Non-small Cell Lung Cancer Treated With Osimertinib
Lead sponsor
Fundacin Biomedica Galicia Sur
Phase
Observational
Overall status
Completed
Start date
March 20, 2024
Completion date
July 12, 2024
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer, quality of life, sarcopenia